Prasugrel is used in combination with low dose aspirin to prevent thrombosis in patients with ACS, including unstable angina pectoris, non-ST elevation myocardial infarction (NSTEMI), and ST elevation myocardial infarction (STEMI), who are planned for treatment with PCI. In studies, prasugrel was more effective than the related clopidogrel but also caused more bleeding. Overall mortality was the same.Prasugrel does not change the risk of death when given to people who have had a STEMI[citation needed] or NSTEMI. Prasugrel does however increase the risk of bleeding and may decrease the risk of further cardiovascular problems. Thus routine use in NSTEMI patients is of questionable value.PRASUGREL is a widely used pharmaceutical formulation for which we are considered an acclaimed supplier to our widely spread clients. We make use of supreme quality chemical compounds in its making along with the help of state-of-the-art machinery. PRASUGREL is appreciated by our customers for its high quality, safe usage, effectiveness and a long life. This has led to its highly rising demands of the same among our competitors in national as well as overseas markets.